ID: ALA2295970

Max Phase: Preclinical

Molecular Formula: C14H17N5OS

Molecular Weight: 303.39

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(CN1CCN(c2ccccc2)CC1)Nc1nncs1

Standard InChI:  InChI=1S/C14H17N5OS/c20-13(16-14-17-15-11-21-14)10-18-6-8-19(9-7-18)12-4-2-1-3-5-12/h1-5,11H,6-10H2,(H,16,17,20)

Standard InChI Key:  DFGOJZAGDMGKGQ-UHFFFAOYSA-N

Associated Targets(non-human)

Ehrlich 1318 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 303.39Molecular Weight (Monoisotopic): 303.1154AlogP: 1.30#Rotatable Bonds: 4
Polar Surface Area: 61.36Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 6.78CX Basic pKa: 5.19CX LogP: 1.15CX LogD: 0.65
Aromatic Rings: 2Heavy Atoms: 21QED Weighted: 0.92Np Likeness Score: -2.89

References

1. Hamama WS, Gouda MA, Badr MH, Zoorob HH.  (2013)  Synthesis, antioxidant, and antitumor evaluation of certain new N-substituted-2-amino-1,3,4-thiadiazoles,  22  (8): [10.1007/s00044-012-0336-z]

Source